We just received data on a new analyst forecast for $XRAY. Needham gave a rating of 'Hold' for $XRAY.
$XRAY Analyst Ratings
Wall Street analysts have issued reports on $XRAY in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 05/12/2025
- UBS issued a "Buy" rating on 05/09/2025
To track analyst ratings and price targets for $XRAY, check out Quiver Quantitative's $XRAY forecast page.
$XRAY Price Targets
Multiple analysts have issued price targets for $XRAY recently. We have seen 8 analysts offer price targets for $XRAY in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Michael Petusky from Barrington Research set a target price of $21.0 on 05/12/2025
- Kevin Caliendo from UBS set a target price of $25.0 on 05/09/2025
- Jason Bednar from Piper Sandler set a target price of $16.0 on 04/30/2025
- Steven Valiquette from Mizuho set a target price of $18.0 on 03/13/2025
- Vik Chopra from Wells Fargo set a target price of $19.0 on 02/28/2025
- Jeffrey Johnson from Baird set a target price of $20.0 on 02/28/2025
- David Saxon from Needham set a target price of $23.0 on 02/28/2025
$XRAY Insider Trading Activity
$XRAY insiders have traded $XRAY stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $XRAY stock by insiders over the last 6 months:
- GREGORY T LUCIER purchased 15,142 shares for an estimated $249,994
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$XRAY Hedge Fund Activity
We have seen 188 institutional investors add shares of $XRAY stock to their portfolio, and 165 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NUANCE INVESTMENTS, LLC removed 4,558,622 shares (-33.7%) from their portfolio in Q1 2025, for an estimated $68,105,812
- PACER ADVISORS, INC. removed 4,503,591 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $67,283,649
- AQR CAPITAL MANAGEMENT LLC added 3,453,662 shares (+119.4%) to their portfolio in Q1 2025, for an estimated $51,597,710
- AMERICAN CENTURY COMPANIES INC removed 2,639,277 shares (-68.1%) from their portfolio in Q1 2025, for an estimated $39,430,798
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 2,177,981 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $32,539,036
- GOLDMAN SACHS GROUP INC added 2,172,343 shares (+827.3%) to their portfolio in Q1 2025, for an estimated $32,454,804
- PRICE T ROWE ASSOCIATES INC /MD/ added 1,412,517 shares (+11.3%) to their portfolio in Q1 2025, for an estimated $21,103,003
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
